Cas:1353947-84-8 Benzo[1,3]dioxole-5-carboxylic acid (pyrrolidin-2-ylMethyl)-aMide hydrochloride manufacturer & supplier

Chemical Name:Benzo[1,3]dioxole-5-carboxylic acid (pyrrolidin-2-ylMethyl)-aMide hydrochloride

CAS.NO:1353947-84-8

Synonyms:Benzo[1,3]dioxole-5-carboxylic acid (pyrrolidin-2-ylMethyl)-aMide hydrochloride

Molecular Formula:C₁₃H₁₇ClN₂O₃

Molecular Weight:284.73868

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Benzo[1,3]dioxole-5-carboxylic acid (pyrrolidin-2-ylMethyl)-aMide hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzo[1,3]dioxole-5-carboxylic acid (pyrrolidin-2-ylMethyl)-aMide hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzo[1,3]dioxole-5-carboxylic acid (pyrrolidin-2-ylMethyl)-aMide hydrochloride Use and application,Benzo[1,3]dioxole-5-carboxylic acid (pyrrolidin-2-ylMethyl)-aMide hydrochloride technical grade,usp/ep/jp grade.

Related News: Taiwan previously participated as an observer at the World Health Assembly, the W.H.O.��s governing body. Benzo[1,3]dioxole-5-carboxylic acid (pyrrolidin-2-ylMethyl)-aMide hydrochloride manufacturer Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application. Benzo[1,3]dioxole-5-carboxylic acid (pyrrolidin-2-ylMethyl)-aMide hydrochloride supplier According to the business type, it can be divided into non-CMO business of APIs and intermediates and CMO business of APIs and intermediates. Benzo[1,3]dioxole-5-carboxylic acid (pyrrolidin-2-ylMethyl)-aMide hydrochloride vendor What’s more, also at the EHA meeting, BeiGene’s Brukinsa showed it could outperform Imbruvica at triggering tumor responses while causing fewer cases of atrial fibrillation, a potentially dangerous heart side effect, in its own head-to-head phase 3 study in previously treated CLL. Benzo[1,3]dioxole-5-carboxylic acid (pyrrolidin-2-ylMethyl)-aMide hydrochloride factory Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.